Status:
COMPLETED
Randomised Double Blind Placebo Controlled Cross Over Design of the Efficacy of Topical Morphine for Inflammatory Pain in Children With Epidermolysis Bullosa
Lead Sponsor:
Institute of Child Health
Conditions:
Epidermylosis Bullosa
Eligibility:
All Genders
4-18 years
Phase:
PHASE4
Brief Summary
Randomised Double blind placebo controlled cross over design study of the efficacy of morphine for inflammatory pain in children with Epidermolysis Bullosa
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- children under 18 years epidermolysis wounds requiring dressing changes
Exclusion
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00231517
Last Update
October 12 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Great Ormond Street Hospital and the Institute of Child health
London, United Kingdom, WC1N 1EH